新锐®(注射用磷酸左奥硝唑酯二钠)

Search documents
扬子江药业集团:锚定世界一流企业 持续追求卓越品牌
Zhong Guo Zhi Liang Xin Wen Wang· 2025-05-08 08:39
Core Viewpoint - Brand building is essential for high-quality development, and Yangtze River Pharmaceutical Group aims to create world-class health brands through its commitment to excellence and innovation [1][6]. Group 1: Brand Development - Yangtze River emphasizes its brand proposition of "Health for Everyone, Everyone for Health" and aims to develop three major brands: "Yangtze River" for Western medicine, "Longfengtang" for traditional Chinese medicine, and "Huyou" for health products [1]. - The company has achieved significant recognition in quality management, winning the "EFQM Global Award" and receiving a "Seven-Star Certification" from the European Foundation for Quality Management [2][3]. Group 2: Quality Management - Yangtze River has won the national quality management award for 20 consecutive years and has received 31 international quality gold awards, showcasing its commitment to quality [3]. - The company has multiple production facilities certified by EU GMP and the US FDA, enhancing its brand recognition in international markets [3]. Group 3: Innovation - Yangtze River is actively engaged in research and development, with over 100 drugs in the pipeline, including more than 20 new drugs in clinical application stages [4]. - The company has launched several health products and is focusing on digital transformation and smart manufacturing to enhance its competitive edge [4]. Group 4: Corporate Responsibility - Yangtze River integrates public welfare into its brand identity, supporting community health initiatives and promoting fitness through events like the Taizhou Marathon [5]. - The company has established 80 standardized planting bases for traditional Chinese medicine, ensuring product quality and traceability throughout the supply chain [5]. Group 5: Strategic Vision - Yangtze River is building a "3+N" brand system to provide comprehensive health services across the entire lifecycle, aligning with the "Healthy China" strategy [6].